
Femasys Inc.
NASDAQ:FEMY
0.97 (USD) • At close June 30, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Femasys Inc. |
Symbool | FEMY |
Munteenheid | USD |
Prijs | 0.966 |
Beurswaarde | 28,154,422 |
Dividendpercentage | 0% |
52-weken bereik | 0.693 - 1.8 |
Industrie | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Ms. Kathy Lee-Sepsick |
Website | https://www.femasys.com |
An error occurred while fetching data.
Over Femasys Inc.
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)